Q2 2020 Holdings
Filed 2020-08-14 | 24 holdings | $51.3M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Charles RIV Labs Intl Inc(CRL) | COM | 159864107 | $22.7M | 130,000 | 44.2% |
| Boston Scientific Corp(BSX) | COM | 101137107 | $21.1M | 600,000 | 41.0% |
| Adaptive Biotechnologies COR(ADPT) | COM | 00650F109 | $7.3M | 150,000 | 14.1% |
| Encompass Health Corp(EHC) | COM | 29261A100 | $34.1K | 550,000 | 0.1% |
| Hologic Inc(HOLX) | COM | 436440101 | $28.5K | 500,000 | 0.1% |
| Baxter Intl Inc(BAX) | COM | 071813109 | $28.4K | 330,000 | 0.1% |
| Horizon Therapeutics PUB LTD | SHS | G46188101 | $24.2K | 436,127 | 0.0% |
| Catalent Inc(CTLTEUR) | COM | 148806102 | $20.5K | 280,000 | 0.0% |
| Iqvia Hldgs Inc(IQV) | COM | 46266C105 | $19.5K | 137,577 | 0.0% |
| Twist Bioscience Corp(TWST) | COM | 90184D100 | $19.0K | 420,510 | 0.0% |
| Nevro Corp(NVROEUR) | COM | 64157F103 | $18.0K | 150,485 | 0.0% |
| Molina Healthcare Inc(MOH) | COM | 60855R100 | $17.8K | 100,000 | 0.0% |
| Bristol-Myers Squibb Co(BMY) | COM | 110122108 | $16.9K | 287,710 | 0.0% |
| Inovalon Hldgs Inc(INOV) | COM CL A | 45781D101 | $14.1K | 733,053 | 0.0% |
| Guardant Health Inc(GH) | COM | 40131M109 | $13.4K | 165,500 | 0.0% |
| Mckesson Corp(MCK) | COM | 58155Q103 | $13.0K | 85,000 | 0.0% |
| Change Healthcare Inc(CHNGUSD) | COM | 15912K100 | $12.9K | 1,147,800 | 0.0% |
| Axonics Modulation Technolog(AXNX*) | COM | 05465P101 | $12.2K | 347,591 | 0.0% |
| Bristol-Myers Squibb Co(BMY)Call | COM | 110122108 | $11.8K | 200,000 | 0.0% |
| Envista Holdings Corporation(NVST) | COM | 29415F104 | $10.5K | 500,000 | 0.0% |
| Inspire MED SYS Inc(INSP) | COM | 457730109 | $10.1K | 116,054 | 0.0% |
| Zimmer Biomet Holdings Inc(ZBH) | COM | 98956P102 | $8.4K | 70,000 | 0.0% |
| Surgery Partners Inc(SGRY) | COM | 86881A100 | $7.8K | 676,652 | 0.0% |
| Royalty Pharma PLC(RPRX) | SHS CL A | G7709Q104 | $4.9K | 100,000 | 0.0% |